9 Meters Biopharma, Inc.
NMTRQ
$0.00
$0.000.00%
| 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.94M | 12.65M | 15.86M | 29.46M | 37.24M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.57M | 3.36M | 2.59M | 1.89M | 1.85M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 684.60K | 17.01M | -- | -- | -- |
| Total Current Assets | 9.20M | 33.02M | 18.45M | 31.35M | 39.09M |
|
|
|||||
| Total Current Assets | 9.20M | 33.02M | 18.45M | 31.35M | 39.09M |
| Net Property, Plant & Equipment | 106.80K | 122.70K | 139.50K | 154.80K | 171.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.00K | 7.30K | 23.54M | 5.60K | 5.60K |
| Total Assets | 9.31M | 33.15M | 42.14M | 31.51M | 39.26M |
|
|
|||||
| Total Accounts Payable | 4.23M | 5.05M | 1.44M | 2.33M | 1.91M |
| Total Accrued Expenses | 5.76M | 4.38M | 6.77M | 6.96M | 6.26M |
| Short-term Debt | 5.07M | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 63.60K | 19.68M | 2.71M | 58.20K | 56.50K |
| Total Finance Division Other Current Liabilities | 454.00K | 1.59M | 1.95M | -- | -- |
| Total Other Current Liabilities | 454.00K | 1.59M | 1.95M | -- | -- |
| Total Current Liabilities | 15.58M | 30.70M | 12.86M | 9.34M | 8.22M |
|
|
|||||
| Total Current Liabilities | 15.58M | 30.70M | 12.86M | 9.34M | 8.22M |
| Long-Term Debt | -- | -- | 15.74M | -- | -- |
| Short-term Debt | 5.07M | -- | -- | -- | -- |
| Capital Leases | 34.80K | 51.40K | 67.50K | 83.20K | 98.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 15.61M | 30.75M | 28.67M | 9.42M | 8.32M |
|
|
|||||
| Common Stock & APIC | 220.18M | 215.01M | 214.14M | 213.41M | 211.13M |
| Retained Earnings | -226.48M | -212.61M | -200.68M | -191.32M | -180.19M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -6.30M | 2.40M | 13.46M | 22.09M | 30.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -6.30M | 2.40M | 13.46M | 22.09M | 30.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -6.30M | 2.40M | 13.46M | 22.09M | 30.94M |
|
|
|||||
